Skip to main content
Testing version — LOERadar is in active testing. Features and data may change.
LOERadar
LOE
Radar
Hub
News
Changes
Search
Log in
Get Started
ZECUITY (SUMATRIPTAN SUCCINATE) | LOERadar
Viewing data from:
Latest
2026-07-01
2026-06-01
2026-05-01
2026-04-01
2026-03-28
2026-02-17
2026-02-10
2025-12-14
2025-02-26
2025-01-25
2024-11-08
2023-07-23
2023-06-15
2023-05-13
2023-01-26
2022-11-22
2022-10-28
2022-09-29
2022-07-09
2022-06-29
2022-04-08
2022-03-09
2021-12-28
2021-05-05
2021-03-12
2020-12-22
2020-11-12
2019-12-14
2019-09-15
ZECUITY
NDA
Get alerts
SUMATRIPTAN SUCCINATE | N202278 | TEVA BRANDED PHARMACEUTICAL PRODUCTS R AND D INC
1 strength
9 unique patents
0 unique exclusivities
Patents
SEC Intel
Revenue
PTAB
Reexams
Litigation
Petitions
Trials
DMF
Approvals
Label
Products
Patent Timeline
9 unique patents by expiration date
Expiring < 1yr (5)
Active (4)
Today
2027
2028
2029
2030
2031
2032
2033
Today
7973058
Apr. 12, 2027
8155737
Apr. 12, 2027
8366600
Apr. 21, 2029
8470853
Apr. 12, 2027
8597272
Apr. 12, 2027
8983594
Nov. 19, 2030
9272137
Sep. 7, 2027
9327114
Oct. 8, 2032
9427578
Apr. 12, 2027
PTAB Proceedings
No IPR/PGR/CBM challenges found at the Patent Trial and Appeal Board
Hatch-Waxman Litigation
No ANDA patent litigation cases (NOS 835) matched from PACER
Citizen Petitions
No FDA citizen petitions matched from Regulations.gov
Products (1)
#001 — EQ 6.5MG BASE/4HR
RLD
9 patents
0 exclusivities
▴
SYSTEM;IONTOPHORESIS | Approved: Jan 17, 2013
Patents (9)
Patent #
Expiration
PED
Drug Substance
Drug Product
Use Code
Delist
7973058
Apr 12, 2027
—
—
—
U-1328
METHOD FOR TREATING ACUTE MIGRAINE IN ADULTS, WITH OR WITHOUT AURA, COMPRISING IONTOPHORETIC TRANSDERMAL DELIVERY OF SUMATRIPTAN OR A SALT THEREOF
—
8155737
Apr 12, 2027
—
—
—
U-1328
METHOD FOR TREATING ACUTE MIGRAINE IN ADULTS, WITH OR WITHOUT AURA, COMPRISING IONTOPHORETIC TRANSDERMAL DELIVERY OF SUMATRIPTAN OR A SALT THEREOF
—
8366600
Apr 21, 2029
—
—
—
U-1327
METHOD FOR TREATING ACUTE MIGRAINE IN ADULTS, WITH OR WITHOUT AURA, COMPRISING IONTOPHORETIC TRANSDERMAL DELIVERY OF SUMATRIPTAN OR A SALT THEREOF, USING A FLOWABLE HYDROGEL FORMULATION
—
8470853
Apr 12, 2027
—
—
—
U-1328
METHOD FOR TREATING ACUTE MIGRAINE IN ADULTS, WITH OR WITHOUT AURA, COMPRISING IONTOPHORETIC TRANSDERMAL DELIVERY OF SUMATRIPTAN OR A SALT THEREOF
—
8597272
Apr 12, 2027
—
—
Yes
—
—
8983594
Nov 19, 2030
—
—
Yes
U-1328
METHOD FOR TREATING ACUTE MIGRAINE IN ADULTS, WITH OR WITHOUT AURA, COMPRISING IONTOPHORETIC TRANSDERMAL DELIVERY OF SUMATRIPTAN OR A SALT THEREOF
—
9272137
Sep 7, 2027
—
—
Yes
—
—
9327114
Oct 8, 2032
—
—
Yes
U-1328
METHOD FOR TREATING ACUTE MIGRAINE IN ADULTS, WITH OR WITHOUT AURA, COMPRISING IONTOPHORETIC TRANSDERMAL DELIVERY OF SUMATRIPTAN OR A SALT THEREOF
—
9427578
Apr 12, 2027
—
—
Yes
U-1328
METHOD FOR TREATING ACUTE MIGRAINE IN ADULTS, WITH OR WITHOUT AURA, COMPRISING IONTOPHORETIC TRANSDERMAL DELIVERY OF SUMATRIPTAN OR A SALT THEREOF
—